Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 18/11/20161 min de leitura
Submission of Premarket Notifications for Magnetic Resonance Diagnostic Devices; Guidance for Industry and Food and Drug Administration Staff; Availability
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing the availability of the guidance entitled "Submission of Premarket Notifications for Magnetic Resonance Diagnostic Devices." This guidance provides a detailed description of the information that should be included in a premarket notification for a magnetic resonance diagnostic device (MRDD).
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →